1. Endo thinks it has the financial flexibility to weather the storm of opioid settlements — Takeda acquires celiac-focused PvP Biologics — Iovance jumps on buyout rumors — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Bioventus

Anonymous board for Bioventus


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    185
    Views:
    24,389
  2. anonymous
    Replies:
    43
    Views:
    6,582
  3. anonymous
    Replies:
    21
    Views:
    2,158
  4. anonymous
    Replies:
    17
    Views:
    4,178
  5. anonymous
    Replies:
    3
    Views:
    1,930
  6. anonymous
    Replies:
    21
    Views:
    3,162
  7. anonymous
    Replies:
    36
    Views:
    4,146
  8. anonymous
    Replies:
    4
    Views:
    1,127
  9. anonymous
    Replies:
    30
    Views:
    5,197
  10. anonymous
    Replies:
    9
    Views:
    1,335
  11. anonymous
    Replies:
    3
    Views:
    1,294
  12. anonymous
    Replies:
    4
    Views:
    1,284
  13. anonymous
    Replies:
    16
    Views:
    1,904
  14. anonymous
    Replies:
    2
    Views:
    1,170
  15. anonymous
    Replies:
    18
    Views:
    2,485
  16. anonymous
    Replies:
    4
    Views:
    1,758
  17. Anonymous
    Replies:
    17
    Views:
    3,486
  18. anonymous
    Replies:
    9
    Views:
    2,976
  19. anonymous
    Replies:
    18
    Views:
    2,355
  20. Anonymous
    Replies:
    178
    Views:
    28,948

Thread Display Options

Loading...